Tandem Meetings 2023 | Optimizing the outcomes of patients with acute and chronic GvHD & recent updates in this space

Catherine Lee • 7 Mar 2023

Tandem Meetings 2023

Catherine Lee, MD, University of Utah, Salt Lake City, UT, shares the key themes that were discussed in an educational session on acute and chronic graft-versus-host disease (GvHD) in bone marrow transplant (BMT) recipients. Dr Lee comments on the importance of early diagnosis and intervention, updates in GvHD prophylaxis strategies, FDA-approved treatments in treatment-refractory GvHD, and the importance of organ-specific supportive care. This interview took place at the 2023 Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR® held in Orlando, FL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Consultancy: Incyte, Fresensius Kabi; Advisory Board: BMS, Kite, Incyte Corporation, Kadmon, Sanofi; Research Funding: Incyte Corporation; Clinical Trial Steering Committee: Incyte Corporation